Overview
Andrew Himelstein is a Hematologist Oncology specialist and a Palliative Medicine provider in Newark, Delaware. Dr. Himelstein is rated as an Experienced provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Familial Prostate Cancer. Dr. Himelstein is currently accepting new patients.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4701 Ogletown Stanton Rd, Suite 3400, Newark, DE 19713
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Skip Viragh Outpatient Cancer Center
Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.
Consultants In Medical Oncology And Hematology PC
John Sprandio is a Hematologist Oncology specialist and a Hematologist in Broomall, Pennsylvania. Dr. Sprandio is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Hairy Cell Leukemia (HCL), Liver Cancer, Familial Colorectal Cancer, and Paget Disease of the Breast.
Pottstown Hospital LLC
Wei Song is a Hematologist Oncology provider in Pottstown, Pennsylvania. Dr. Song is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Endoscopy, and Adenoidectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Himelstein isDistinguished. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Himelstein isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Himelstein isDistinguished. Learn about Lung Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Paget Disease of the BreastDr. Himelstein isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Himelstein isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Acquired HemophiliaDr. Himelstein isAdvanced. Learn about Acquired Hemophilia.
- Acute Mountain SicknessDr. Himelstein isAdvanced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Himelstein isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AngiosarcomaDr. Himelstein isAdvanced. Learn about Angiosarcoma.
- Appendix CancerDr. Himelstein isAdvanced. Learn about Appendix Cancer.
- AstrocytomaDr. Himelstein isAdvanced. Learn about Astrocytoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Himelstein isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Hepatic Porphyria (AHP)Dr. Himelstein isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Himelstein isExperienced. Learn about Acute Intermittent Porphyria.
- Adult Soft Tissue SarcomaDr. Himelstein isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Himelstein isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Himelstein isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
